checkAd

     258  0 Kommentare Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness - Seite 3

    For Inquiries:

    Chas Schultz
    Executive Director, Corporate Communications and Patient Advocacy
    Lexicon Pharmaceuticals
    (281) 863-3421
    cschultz@lexpharma.com

    Lesen Sie auch

     


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness - Seite 3 Lexicon Has Reduced Its Outstanding Debt by Approximately 90% in Third Quarter 2020THE WOODLANDS, Texas, Sept. 23, 2020 (GLOBE NEWSWIRE) - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that it has entered into separate, …